logo
Select company
Select metric
32.74%Cash to Assets Ratio
VS
Market
85
Sector
60
Industry
48
History
50
$ 6.45Close
$ 1.06 - $ 6.45 52-Week Range
Ticker Information

Ticker

ATAI

Company Name

ATAI LIFE SCIENCES NV

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ATAI LIFE SCIENCES NV - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ATAI - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 189.2M$ 61.94M32.74%
3/31/2025$ 195.78M$ 48.29M24.66%
12/31/2024$ 159.39M$ 17.5M10.98%
9/30/2024$ 197.52M$ 29.96M15.17%
6/30/2024$ 215.78M$ 19.33M8.96%
3/31/2024$ 269.12M$ 18.87M7.01%
12/31/2023$ 293.48M$ 45.03M15.34%
9/30/2023$ 308.22M$ 76.49M24.82%
6/30/2023$ 253.59M$ 141.09M55.64%
3/31/2023$ 280.72M$ 185.88M66.22%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ATAI LIFE SCIENCES NV's latest trailing twelve months (TTM) Cash to Assets stands at 87.18%.
  • Over the past 5 years, ATAI LIFE SCIENCES NV's average Cash to Assets has been 44.58%.
  • The median Cash to Assets for ATAI LIFE SCIENCES NV during this period was 32.74%
  • ATAI LIFE SCIENCES NV reached its highest Cash to Assets over the past 5 years at 89.66%.
  • The lowest Cash to Assets recorded by ATAI LIFE SCIENCES NV in the same timeframe 7.01%

ATAI LIFE SCIENCES NV's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
UPB : UPSTREAM BIO INC 10.86%KALV : KALVISTA PHARMACEUTICALS INC 57.68%VSTM : VERASTEM INC 83.72%CNTB : CONNECT BIOPHARMA HOLDINGS LTD 49.12%INBX : INHIBRX BIOSCIENCES INC 87.95%PROK : PROKIDNEY CORP 22.83%SION : SIONNA THERAPEUTICS INC 11.92%NTRB : NUTRIBAND INC 68.74%ORMP : ORAMED PHARMACEUTICALS INC 9.77%TRVI : TREVI THERAPEUTICS INC 56.19%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ATAI LIFE SCIENCES NV is calculated as follows: CashnEq [ $ 97.25M ] / Assets [ $ 111.55M ]
(=) Cash to Assets [ 87.18% ]

ATAI - Cash to Assets Ratio, Last 5 years

7.01%

Minimum

Mar 31, 2024

89.66%

Maximum

Jun 30, 2021

44.58%

Average

32.74%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%